Yüklüyor......
Emerging Therapies in Immune Thrombocytopenia
Immune thrombocytopenia (ITP) is a rare autoimmune disorder caused by peripheral platelet destruction and inappropriate bone marrow production. The management of ITP is based on the utilization of steroids, intravenous immunoglobulins, rituximab, thrombopoietin receptor agonists (TPO-RAs), immunosup...
Kaydedildi:
| Yayımlandı: | J Clin Med |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7958340/ https://ncbi.nlm.nih.gov/pubmed/33801294 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10051004 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|